Chapter 22: Sexual Violence

Sexual Violence examines the epidemiology of sexual assault, identifying vulnerable populations such as women, children, the elderly, and members of the LGBTQ community, while analyzing the psychological profiles of perpetrators who often exhibit antisocial traits and a history of abuse. A major focus is placed on the specific dynamics of drug-facilitated sexual assault, detailing the pharmacological effects of "date rape drugs" like gamma-hydroxybutyric acid (GHB), flunitrazepam (Rohypnol), and ketamine, alongside the prevalence of alcohol involvement. The summary delineates the critical role of the Sexual Assault Response Team (SART) and the specialized expertise of the Sexual Assault Nurse Examiner (SANE) in providing compassionate, trauma-informed care. Key clinical concepts include the assessment and management of Rape-Trauma Syndrome, which is categorized into an acute phase of disorganization marked by shock and emotional lability, and a long-term phase of reorganization that may evolve into Post-Traumatic Stress Disorder (PTSD) with symptoms like flashbacks, phobias, and somatic disturbances. The text outlines the meticulous protocols required for forensic examination, including the use of rape kits, the preservation of chain of custody for DNA evidence, and the creation of body maps to document physical trauma. Furthermore, it covers essential medical interventions such as prophylaxis for sexually transmitted infections (STIs), emergency contraception for pregnancy prevention, and risk assessment for HIV and hepatitis, all while emphasizing the legal and ethical necessity of obtaining informed consent and maintaining strict confidentiality to help the patient transition from victim to survivor.